ESR1 and breast cancer: Additionally, using another public database, a Kaplan–Meier analysis of breast cancer patients indicated that high NR2F1‐AS1 levels correlated with poor overall survival (OS) and distant metastasis‐free survival (DMFS), even when restricted to ER‐positive cases (Fig 3E‐F).